accompanying editorial re early trial results of adding everolimus to herceptin once
tumor resistant to herceptin
J Clin Oncol. 2011 Jul 5. [Epub ahead of print]
Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Can There Be Too Many Active Drugs?
Chandarlapaty S, Modi S.
Source
Memorial Sloan-Kettering Cancer Center, New York, NY.
PMID: 21730267
|